CD8A and COVID-19: A study of five KTRs with polymerase chain reaction (PCR)-confirmed COVID-19 found that they had reactive SARS-CoV-2-specific CD4+ and CD8+ T cells from 2 to 6 weeks after symptom onset and did not differ from patients on hemodialysis.